Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
2438 Results for "
decrease
" in MedChemExpress (MCE) Product Catalog:
Products (2438)
2438 Results for "decrease" in MCE Product Catalog:
Art. -Nr.: HY-N1428CA
CAS. Nr.: 3522-50-7
Art. -Nr.: HY-N7118R
CAS. Nr.: 58207-19-5
Target:
Clindamycin (hydrochloride monohydrate) (Standard) is the analytical standard of Clindamycin (hydrochloride monohydrate). This product is intended for research and analytical applications. Clindamycin hydrochloride monohydrate is an oral protein synthesis inhibitory agent that has the ability to suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Clindamycin hydrochloride monohydrate resistance results from enzymatic methylation of the antibiotic binding site in the 50S ribosomal subunit (23S rRNA). Clindamycin hydrochloride monohydrate decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla) .
Art. -Nr.: HY-P10332
Target:
Forschungsgebiete:
Art. -Nr.: HY-P11321
Synonyms: acyl-GIP
Target:
Forschungsgebiete:
IUB0271 (acyl-GIP) is a glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist with blood-brain barrier permeability. IUB0271 activates the GIPR signaling pathway, inhibits food intake and weight gain, and induces cFos neuron activation in the area postrema. IUB0271 enhances lipid clearance and induces systemic fatty acid oxidation. IUB0271 improves dyslipidemia, reduces atherosclerotic plaque formation and decreases adipocyte volume. IUB0271 can be used in studies related to obesity, dyslipidemia and atherosclerosis .
Art. -Nr.: HY-P11321A
Synonyms: acyl-GIP hydrochloride
Target:
Forschungsgebiete:
IUB0271 hydrochloride (acyl-GIP hydrochloride) is a glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist with blood-brain barrier permeability. IUB0271 hydrochloride activates the GIPR signaling pathway, inhibits food intake and weight gain, and induces cFos neuron activation in the area postrema. IUB0271 hydrochloride enhances lipid clearance and induces systemic fatty acid oxidation. IUB0271 hydrochloride improves dyslipidemia, reduces atherosclerotic plaque formation and decreases adipocyte volume. IUB0271 hydrochloride can be used in studies related to obesity, dyslipidemia and atherosclerosis .
Art. -Nr.: HY-P2446
CAS. Nr.: 83539-08-6
Synonyms: APTAA-LHRH
Target:
Forschungsgebiete:
Art. -Nr.: HY-P2483
CAS. Nr.: 148796-86-5
Target:
Forschungsgebiete:
Art. -Nr.: HY-P2483B
Target:
Forschungsgebiete:
Art. -Nr.: HY-P2657
CAS. Nr.: 138067-14-8
Forschungsgebiete:
Target:
Forschungsgebiete:
Dextranase, Trichoderma reesei belongs to glycoside hydrolase family 49. It catalyzes the hydrolysis of α-1,6-glycosidic linkages in dextran via a single-displacement reaction, ultimately releasing shorter isomaltooligosaccharides. Dextranase, Trichoderma reesei reduces the molecular size of dextran, inhibits the formation of insoluble dextran and dental plaque, and decreases the viscosity of dextran-contaminated sugar juice. Dextranase, Trichoderma reesei can be used in relevant research in fields such as chemical production, including beer manufacturing, feed additives, and toothpaste formulations .
Art. -Nr.: HY-P2840A
Target:
Forschungsgebiete:
Dextranase, Penicillium sp. belongs to glycoside hydrolase family 49. It catalyzes the hydrolysis of α-1,6-glycosidic linkages in dextran via a single-displacement reaction, ultimately releasing shorter isomaltooligosaccharides. Dextranase, Penicillium sp. reduces the molecular size of dextran, inhibits the formation of insoluble dextran and dental plaque, and decreases the viscosity of dextran-contaminated sugar juice. Dextranase, Penicillium sp. can be used in relevant research in fields such as chemical production, including beer manufacturing, feed additives, and toothpaste formulations .
Art. -Nr.: HY-P3419A
Forschungsgebiete:
Art. -Nr.: HY-P4683
CAS. Nr.: 129520-65-6
Target:
Forschungsgebiete:
Art. -Nr.: HY-P4683A
Target:
Forschungsgebiete:
Art. -Nr.: HY-P5272
CAS. Nr.: 112844-49-2
Target:
Forschungsgebiete:
Art. -Nr.: HY-P5484
CAS. Nr.: 1629248-30-1
Art. -Nr.: HY-P99149
Target:
Forschungsgebiete:
Art. -Nr.: HY-P991517
Forschungsgebiete:
BI-836858 is a fully human anti-CD33 monoclonal antibody. BI-836858 blocks CD33-mediated inhibitory signaling pathways in MDS bone marrow cells and reduces the expression of IL-10 and TGFβ. BI-836858 decreases the secretion of immunosuppressive cytokines and reactive oxygen species (ROS)-induced genomic instability, restoring bone marrow hematopoietic function. BI-836858 can be used for research on myelodysplastic syndromes (MDS) and AML .
Art. -Nr.: HY-W127841
CAS. Nr.: 121633-50-9
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
